The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously publis...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ce6cd58e55642fabacee8cab9316299 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5ce6cd58e55642fabacee8cab9316299 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5ce6cd58e55642fabacee8cab93162992021-11-08T07:48:25ZThe Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study1664-229510.3389/fneur.2021.767480https://doaj.org/article/5ce6cd58e55642fabacee8cab93162992021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.767480/fullhttps://doaj.org/toc/1664-2295Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously published research has confirmed risk factors that may impact the course of PSP and CBS, among them hypertension and diabetes. Less data is available regarding prediabetes and glycemic variability. In this study, 26 patients with clinical diagnoses of PSP and CBS were examined using glycated hemoglobin and perfusion single-photon emission tomography (SPECT). Patients were divided into two groups—PSP/CBS patients with glycated hemoglobin (HbA1c) below and above 5.7%. The results of the perfusion evaluation were compared with the values from healthy volunteers from the software's database. A decrease in perfusion in certain regions of interest was observed among patients affected by increased glycemic variability. A more pronounced decrement in perfusion was observed only in some regions of interest—the hippocampus, pons, left thalamus, right insula. The results indicated that, among PSP/CBS patients, individuals with more pronounced glycemic variability had more severe hypoperfusion in certain brain regions in comparison with PSP/CBS patients without carbohydrate metabolism disorders. Due to the fact that PSP and CBS are associated with cognitive impairment, an additional decrease in perfusion in the hippocampal area may impact the rate of cognitive deterioration.Piotr AlsterAnna DunalskaBartosz MigdaNatalia MadetkoLeszek KrólickiFrontiers Media S.A.articlePSPCBSSPECTprediabetesperfusionNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
PSP CBS SPECT prediabetes perfusion Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
PSP CBS SPECT prediabetes perfusion Neurology. Diseases of the nervous system RC346-429 Piotr Alster Anna Dunalska Bartosz Migda Natalia Madetko Leszek Królicki The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
description |
Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously published research has confirmed risk factors that may impact the course of PSP and CBS, among them hypertension and diabetes. Less data is available regarding prediabetes and glycemic variability. In this study, 26 patients with clinical diagnoses of PSP and CBS were examined using glycated hemoglobin and perfusion single-photon emission tomography (SPECT). Patients were divided into two groups—PSP/CBS patients with glycated hemoglobin (HbA1c) below and above 5.7%. The results of the perfusion evaluation were compared with the values from healthy volunteers from the software's database. A decrease in perfusion in certain regions of interest was observed among patients affected by increased glycemic variability. A more pronounced decrement in perfusion was observed only in some regions of interest—the hippocampus, pons, left thalamus, right insula. The results indicated that, among PSP/CBS patients, individuals with more pronounced glycemic variability had more severe hypoperfusion in certain brain regions in comparison with PSP/CBS patients without carbohydrate metabolism disorders. Due to the fact that PSP and CBS are associated with cognitive impairment, an additional decrease in perfusion in the hippocampal area may impact the rate of cognitive deterioration. |
format |
article |
author |
Piotr Alster Anna Dunalska Bartosz Migda Natalia Madetko Leszek Królicki |
author_facet |
Piotr Alster Anna Dunalska Bartosz Migda Natalia Madetko Leszek Królicki |
author_sort |
Piotr Alster |
title |
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
title_short |
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
title_full |
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
title_fullStr |
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
title_full_unstemmed |
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study |
title_sort |
rate of decrease in brain perfusion in progressive supranuclear palsy and corticobasal syndrome may be impacted by glycemic variability—a pilot study |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/5ce6cd58e55642fabacee8cab9316299 |
work_keys_str_mv |
AT piotralster therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT annadunalska therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT bartoszmigda therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT nataliamadetko therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT leszekkrolicki therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT piotralster rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT annadunalska rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT bartoszmigda rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT nataliamadetko rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy AT leszekkrolicki rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy |
_version_ |
1718442812310028288 |